*

A shop（Professional forum）：Molecular diagnosis, antibody drugs, cell and gene therapy, new drug development and clinical progress

*

B shop（Excellent forum + wonderful activities）：Opening ceremony, youth forum, guest interview, interview and negotiation, immersion exhibition, special clothing and standard exhibition, public welfare activities, friendship football match and other forms and contents

Industry experts

*

Expert Committee: zhoucaicun，Director of oncology department, Shanghai Pulmonary Hospital Affiliated to Tongji University；Zhou Jianfeng，Director of clinical research center, director of Hematology Department of Wuhan Tongji Hospital; Zhang Lianshan, senior vice president and President of global R & D, Hengrui medicine；Li Ning，Chief executive officer, Junshi biology；Chen Zhisheng，CEO, Yao Ming biology；Li Jing，Executive director and vice president, mebotheco；Zhou Daixing，General manager, berry gene；Wang Liqun，Founder and President, Fosun Kate；Li Yiping，Co founder, chairman and chief executive officer, Yao mingjuno；Zhang Jinhua，Founder and chairman of caribou medical

*

Executive Committee: Zhu Zhenping，President and chief science officer, Sansheng Guojian；Liu Jun，CEO, Dongyao pharmaceutical；Gu Jijie，Executive vice president and chief scientific officer, Yao Ming biology；Guo Tong，President, gemstone flower Pharmaceutical Technology；Wen Danyi，Chairman and CEO, Lidi Bio；Zhouguoying，CEO&chairman，Yinuowei medicine；Shi bin，SAPA GP-Former president，SAPA China-director；Chenshaoyu，managing partner，Arnold & Porter LLP；Fan Xiaohu，CSO&Co founders，Nanjing legend

*

联合主办方：China Anti Cancer Association, precision medicine special committee of China Society of bioengineering, Hengrui medicine, Junshi biology, Dongyao pharmaceutical, Yaoming biology, Yaoming junuo, berry gene, reindeer medical, Yinuo micro medicine, baoshihua medical technology, Lidi biology, Decheng capital、Illumina、KIP

【Opening report】Opportunities and challenges of China's biological industry in the post epidemic Era

【dialogue】Ten years of biopharmaceutical innovation

Academician Jiang Hualiang, Chinese Academy of Sciences; Dr. Zhang Lianshan, senior vice president and global R & D president of Hengrui medicine

【Dialogue】Prospect of precision medicine

【Interview】Next decade, a better era, more intense competition

Chair: Xu Xiaoou, executive director of direct investment department, Goldman Sachs (Asia) Co., Ltd;

Guests: Song Ruilin, executive president of China pharmaceutical innovation promotion association; Zhou Daixing, general manager, berry gene

【Award ceremony】2020 Yimao biological industry annual award ceremony

Molecular diagnosis, antibody drugs, cell and gene therapy, new drug research and development, clinical progress, investment and financing

Highlights of professional forum of Library B

New crown topics: industrialization opportunities, seminar of Wuxi apptec, biological products (Youth Forum), biological drugs, precision medicine, gene therapy technology (Youth Forum)

Three professional closed door meetings

High level closed door meeting of biomedicine: accelerating innovation, CO sponsor: FDA expert Association

Closed door meeting of precision medicine: norms and standards, CO sponsor: precision medicine special committee of Chinese society of Bioengineering

Biopharmaceutical payment Innovation: Prospect of business insurance trend, CO sponsor: iqvia